Co-Diagnostics, Inc.
Co-Diagnostics, Inc. (CODX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CODX · as of Jun 8, 2026
Key Statistics
Explore Co-Diagnostics, Inc. Data
codx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 40.0%
The CODX analyst consensus is Hold, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $180.00, representing +3412.20% upside from the current price of $5.13.
Competitors & Peers
codx competitorsCODX
ADGM
AEMD
ALUR
DWTX
NVNOStock Performance
Full HistoryAbout Co-Diagnostics, Inc.
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nuclei…
what is co-diagnostics, inc. · codx stock overview · co-diagnostics, inc. company profile · who is co-diagnostics, inc. ceo · codx NASDAQ · co-diagnostics, inc. headquarters · co-diagnostics, inc. business segments
About Stock Overview & Key Data
Co-Diagnostics, Inc. (CODX) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 12, 2017. As of the latest trading session, CODX stock price is $5.13, with a market capitalization of $5.7M. The stock has returned -42.73% over the past 12 months and +0.99% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Co-Diagnostics, Inc. stock is Hold, with an average 12-month price target of $180.00. In fiscal year 2025, Co-Diagnostics, Inc. reported revenue of $622489.00 and net income of -$46.9M. For detailed data — including Co-Diagnostics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Co-Diagnostics, Inc. (CODX) stock price is $5.13. The stock is traded on NASDAQ under the ticker symbol CODX. The 52-week range is $1.26 – $46.50.